Tower Research Capital LLC TRC Boosts Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Tower Research Capital LLC TRC grew its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 72.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,514 shares of the health services provider’s stock after buying an additional 15,364 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Teladoc Health were worth $332,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Arizona State Retirement System increased its position in shares of Teladoc Health by 1.8% during the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider’s stock worth $452,000 after purchasing an additional 859 shares in the last quarter. Canada Pension Plan Investment Board increased its position in shares of Teladoc Health by 0.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider’s stock worth $2,079,000 after purchasing an additional 1,200 shares in the last quarter. Summit Investment Advisors Inc. boosted its stake in Teladoc Health by 8.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider’s stock worth $164,000 after buying an additional 1,331 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in Teladoc Health by 22.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider’s stock worth $73,000 after buying an additional 1,439 shares during the last quarter. Finally, Lindbrook Capital LLC boosted its stake in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock worth $33,000 after buying an additional 1,612 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 2.9 %

Shares of TDOC stock opened at $6.99 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market capitalization of $1.22 billion, a P/E ratio of -1.21 and a beta of 1.73. The company has a 50 day moving average price of $8.10 and a 200 day moving average price of $9.51. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.58% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday. Stifel Nicolaus lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday. Jefferies Financial Group lowered their price objective on Teladoc Health from $10.00 to $8.00 and set a “hold” rating on the stock in a research note on Monday, April 21st. Bank of America lowered their price objective on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating on the stock in a research note on Friday, April 11th. Finally, The Goldman Sachs Group decreased their price target on Teladoc Health from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $9.81.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.